Stephens raised the firm’s price target on Ensign Group (ENSG) to $170 from $165 and keeps an Overweight rating on the shares. Despite Ensign contending with uncertainty surrounding the long-term Medicaid reimbursement backdrop for Skilled Nursing Facilities, fundamentals “have not wavered,” says the analyst, who raises estimates following the company’s Q2 report.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENSG:
